- Report
- April 2022
- 40 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2022
- 100 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 113 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- July 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
The Cholesterol Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat conditions related to the heart and circulatory system. Cholesterol Drugs are used to reduce levels of low-density lipoprotein (LDL) cholesterol, which is a major risk factor for cardiovascular disease. These drugs are typically prescribed to patients with high cholesterol levels, or to those at risk of developing cardiovascular disease. Common types of Cholesterol Drugs include statins, bile acid sequestrants, fibrates, and cholesterol absorption inhibitors.
Some companies in the Cholesterol Drug market include Pfizer, Merck, AstraZeneca, Sanofi, and Novartis. Show Less Read more
